Viewing StudyNCT00516802



Ignite Creation Date: 2024-05-05 @ 6:38 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00516802
Status: COMPLETED
Last Update Posted: 2009-05-15
First Post: 2007-08-13

Brief Title: A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine
Sponsor: AstraZeneca
Organization: AstraZeneca

Organization Data

Organization: AstraZeneca
Class: INDUSTRY
Study ID: KU36-73
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: AstraZeneca
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
KuDOS Pharmaceuticals Limited INDUSTRY